scholarly journals Uterine fibroid treatment with magnetic resonance-guided focused ultrasound surgery (MRgFUS): Inclusion and exclusion criteria

Gynecology ◽  
2016 ◽  
Vol 4 (1) ◽  
pp. 1
Author(s):  
Sara Mascaretti ◽  
Fabiana Ferrari ◽  
Anna Miccoli ◽  
Francesco Arrigoni ◽  
Carlo Masciocchi ◽  
...  
Keyword(s):  
Magnetic Resonance ◽  
Uterine Fibroid ◽  
Focused Ultrasound ◽  
Exclusion Criteria ◽  
Ultrasound Surgery ◽  
Focused Ultrasound Surgery

scholarly journals Updated Costs of Uterine Fibroid Treatments Including Focused Ultrasound Surgery

2018 ◽  
Author(s):  
Bijan J. Borah ◽  
Elizabeth A. Stewart
Keyword(s):  
Magnetic Resonance ◽  
Focused Ultrasound ◽  
Treatment Options ◽  
Uterine Fibroids ◽  
Reproductive Age ◽  
Invasive Treatment ◽  
Ultrasound Surgery ◽  
Non Invasive ◽  
Focused Ultrasound Surgery ◽  
Reproductive Age Women

Uterine leiomyomas (fibroids) affect 20–40% of reproductive age women and are the major indication for hysterectomy. Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) is a new, potentially disruptive, non-invasive and uterine-sparing treatment option that has been shown to yield similar or better clinical outcomes than other uterine-sparing interventions. However, the costs of MRgFUS and other minimally-invasive treatment options have not been studied using US practice data. This study attempts to fill this void. And since uterine fibroids are the first FDA-approved indication for MRgFUS treatment, this study may also have implications for other indications which are now investigational.

Sign in / Sign up

Export Citation Format

Share Document